Investment Q&A

Q: Does the recent earnings affect your view on SOUN as a longer term hold? Would you be comfortable initiating a position now? Thank-you

Q: WULF Please comment on the company and your thoughts on GOOGL stake/partnership with them.

Q: Can you please comment on E's recent Q and it's future prospects. Jason Donville at DKAM sees it as a potential multibagger and I am wondering if this is one of his rare misses or if he is just a little early.

Thanks
Scott

Q: This stock is up 50% in less than a month and is at a 52 week high it also will be making about 270 million going forward this year. They get to keep 90% of that. My simple math has them at a P/E of 6.4 on a forward basis if they don’t overachieve. There drug is getting traction into the hospitals and with the doctors due to its drug profile.

Aurina has another drug in the pipeline going into phase two that looks good and I hope they go after rheumatoid arthritis. To me everything looks good here. This is my fun stock to stop me from becoming too bored and is finally becoming exciting.

What do you folks think is going on here regarding the big move in the stock price and where it could go. Looks like the existing drug revenue tops out an around 600 million annually.

Q: Your thoughts on this stock and whether it is a buy / good bet at this price would be helpful.

Q: Please comment on results, outlook, and the jump in share price. Can it climb higher?

Q: Thoughts on DEFI Q2 earnings and raised guidance and is this a good entry point?

Q: Post earnings results, would you be comfortable adding TVK shares at current level, Today ?

Thank You

Q: Where did Well's profitability go??

They had positive EPS now Google is showing $-0.52 EPS? What happened?

Q: Can I have your opinion on Zomd quarterly report?

Q: Some of my favourite smaller cap stocks. Would appreciate a ranking on 2 fronts. First, please rank from 1 to 12 for the upside potential for the stock price over the next 5 years. Second, please rank from 1 to 12 the downside risk for the stock price over the same time frame. Understood that all are higher than average risk. ATZ, BRM, CPH, GRID, HPS.A, KSI, MDA, PNG, PRL, TGH, VHI, ZDC

Q: Please comment on the 2nd q numbers. Thanks.

Q: Results could be described as stable, but I don't like the fact that they had to renegotiate covenants, and that the extension goes only until September30, 2025.
Your opinion on both the results and the covenant issue would be most welcome.
Thanks folks!

Q: WELL reported good results, or at least they seemed good. In early questions, 5i agreed. Stock opened higher then fell off a cliff ending down 32c. What does the market see about the results that initially wasn't obvious. Or is this just a glorious time to add to position?

Q: Hello Team,

You mentioned earlier that when/if Small Caps go they should "GO".

Can you give you top 3-4 Canadian and top 3-4 US small caps that you think will "GO"!

Thanks.

Q: Your analysis of recent earnings would be great! I like that the backlog is at a high and am hoping this might be a signal that this will move higher in the next few quarters.

Q: Can you explain the relationship between these 2 companies and the significance\impact of results currently released by Healwell. Thanks John

Q: Hi there, your thoughts on AIDX after their results and conference call?

Q: hi folks:

did well with this company in the past

i see it has sold off quite hard; it did get a big trump bump

can you pls provide an update? and would you consider it worthwhile at this point

thanks in advance

Q: Hi 5i, I'd appreciate your current take on Viavi Solutions. It appears to be a viable small cap that could benefit from the AI build-out. Thanks!